JP Patent

JP4590158B2 — グルコース再吸収阻害剤およびレチノイド−ｘ受容体モジュレーターを含んで成る併用療法

Assigned to オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド · Expires 2010-12-01 · 15y expired

What this patent protects

Patent listed against Farxiga.

Drugs covered by this patent

Patent Metadata

Patent number
JP4590158B2
Jurisdiction
JP
Classification
—
Expires
2010-12-01
Drug substance claim
No
Drug product claim
No
Assignee
オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.